Paper34833334
Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives.
Imam SS and 7 others. Polymers (Basel), 2021. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives. Papers, record 34833334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34833334
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References185
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14511674 | Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/14511674 | PubMed |
| 2 | 20951455 | Antimicrobial properties of chitosan and mode of action: a state of the art review. | Int J Food Microbiol | 2010 | https://conductscience.org/library/papers/20951455 | PubMed |
| 3 | 30634637 | The Therapeutic Potential of Naringenin: A Review of Clinical Trials. | Pharmaceuticals (Basel) | 2019 | https://conductscience.org/library/papers/30634637 | PubMed |
| 4 | 16081279 | Curcumin: the story so far. | Eur J Cancer | 2005 | https://conductscience.org/library/papers/16081279 | PubMed |
| 5 | 29389599 | Recent developments on the extraction and application of ursolic acid. A review. | Food Res Int | 2018 | https://conductscience.org/library/papers/29389599 | PubMed |
| 6 | 29719446 | Ursolic acid in health and disease. | Korean J Physiol Pharmacol | 2018 | https://conductscience.org/library/papers/29719446 | PubMed |
| 7 | 31223096 | Ferulic Acid: A Promising Therapeutic Phytochemical and Recent Patents Advances. | Recent Pat Inflamm Allergy Drug Discov | 2019 | https://conductscience.org/library/papers/31223096 | PubMed |
| 8 | 30086329 | Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals. | Biotechnol Adv | 2020 | https://conductscience.org/library/papers/30086329 | PubMed |
| 9 | 25148980 | Nutraceutical delivery systems: resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. | Food Chem | 2015 | https://conductscience.org/library/papers/25148980 | PubMed |
| 10 | 16445946 | Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. | Life Sci | 2006 | https://conductscience.org/library/papers/16445946 | PubMed |
| 11 | 15779070 | Metabolism and bioavailability of trans-resveratrol. | Mol Nutr Food Res | 2005 | https://conductscience.org/library/papers/15779070 | PubMed |
| 12 | 15051852 | Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. | J Nutr | 2004 | https://conductscience.org/library/papers/15051852 | PubMed |
| 13 | 12695345 | Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. | Drug Metab Dispos | 2003 | https://conductscience.org/library/papers/12695345 | PubMed |
| 14 | 26609763 | A novel 10-hydroxycamptothecin-glucoside from the fruit of Camptotheca acuminata. | Nat Prod Res | 2016 | https://conductscience.org/library/papers/26609763 | PubMed |
| 15 | 14684281 | Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. | J Control Release | 2004 | https://conductscience.org/library/papers/14684281 | PubMed |
| 16 | 34333289 | Chitosan-tripolyphosphate nanoparticles designed to encapsulate polyphenolic compounds for biomedical and pharmaceutical applications - A review. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/34333289 | PubMed |
| 17 | 23194884 | Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). | Int J Pharm | 2013 | https://conductscience.org/library/papers/23194884 | PubMed |
| 18 | 14519824 | Mechanisms of cancer prevention by tea constituents. | J Nutr | 2003 | https://conductscience.org/library/papers/14519824 | PubMed |
| 19 | 18203131 | Ursolic acid: an anti- and pro-inflammatory triterpenoid. | Mol Nutr Food Res | 2008 | https://conductscience.org/library/papers/18203131 | PubMed |
| 20 | 29157022 | Phytochemical based nanomedicines against cancer: current status and future prospects. | J Drug Target | 2018 | https://conductscience.org/library/papers/29157022 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797275 | Harnessing Medicinal Plants Through Advanced Drug Delivery: A New Era in Type 2 Diabetes Management. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797275 | PubMed |
| 42410491 | Molecular insights into the protective role of nano-naringin in mancozeb-induced testicular damage and infertility. | Biol Res | 2026 | https://conductscience.org/library/papers/42410491 | PubMed |
| 42310631 | Hepatorenal protective and antitumor effects of astaxanthin-loaded chitosan nanoparticles against ehrlich ascites carcinoma in mice through antioxidant, anti-inflammatory, and apoptotic pathway modulation. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42310631 | PubMed |
| 41993590 | Bridging bioactive metabolites of Phoenix dactylifera L. with advanced nanocarrier technologies for mucoadhesive drug delivery. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41993590 | PubMed |
| 41948610 | Nanoengineered phytochemicals overcome blood-brain barrier constraints in neurodegenerative disorders. | Front Neurol | 2026 | https://conductscience.org/library/papers/41948610 | PubMed |
| 41828721 | Synergistic Anticancer Effects of Vitamin D and Plant-Derived Compounds: Molecular Mechanisms, Therapeutic Potential, and Nanotechnology-Enabled Delivery Approaches. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828721 | PubMed |
| 41501298 | Chitosan from shrimp shell waste as a carrier for frankincense nanoparticles with enhanced antimicrobial activity. | Sci Rep | 2026 | https://conductscience.org/library/papers/41501298 | PubMed |
| 41394126 | Targeting L-arginine/NO/cGMP/KATP pathway by phytochemicals: therapeutic applications and clinical perspectives. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41394126 | PubMed |
| 41185868 | Recent advancement in polymeric nanoparticles for oral chemotherapy: Transforming cancer treatment. | Bioimpacts | 2025 | https://conductscience.org/library/papers/41185868 | PubMed |
| 41034621 | Chitosan-encapsulated Aloe vera nanoparticles outperform carrier-free forms in enhancing MSCs therapy for amikacin nephrotoxicity. | Sci Rep | 2025 | https://conductscience.org/library/papers/41034621 | PubMed |
| 40807593 | Nanomaterials for Smart and Sustainable Food Packaging: Nano-Sensing Mechanisms, and Regulatory Perspectives. | Foods | 2025 | https://conductscience.org/library/papers/40807593 | PubMed |
| 40708852 | Dual-loaded ZnO and Se nanoparticles in chitosan/alginate bio-composite: synthesis, cytotoxicity, antioxidant activity, and anti-cervical cancer potential. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40708852 | PubMed |
| 40649846 | GSH/pH-Responsive Chitosan-PLA Hybrid Nanosystems for Targeted Ledipasvir Delivery to HepG2 Cells: Controlled Release, Improved Selectivity, DNA Interaction, Electrochemical and Stopped-Flow Kinetics Analyses. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649846 | PubMed |
| 40599396 | How Effective are Key Phytocompound Carrying Polysaccharide Nanocarriers as Anti-Breast Cancer Therapy? A Comprehensive Review of the Literature. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40599396 | PubMed |
| 40417762 | Recent Expansions and Future Outlook in the Delivery of Poorly Soluble Phytoconstituents through Solid Dispersion Technique. | Recent Adv Drug Deliv Formul | 2026 | https://conductscience.org/library/papers/40417762 | PubMed |
| 40284459 | Vesicular Carriers for Phytochemical Delivery: A Comprehensive Review of Techniques and Applications. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284459 | PubMed |
| 40142072 | Chitosan and Its Derivatives as Nanocarriers for Drug Delivery. | Molecules | 2025 | https://conductscience.org/library/papers/40142072 | PubMed |
| 40072692 | Recent advancements in genistein nanocarrier systems for effective cancer management. | Med Oncol | 2025 | https://conductscience.org/library/papers/40072692 | PubMed |
| 39940873 | Chitosan Nanoparticle-Encapsulated Cordyceps militaris Grown on Germinated Rhynchosia nulubilis Reduces Type II Alveolar Epithelial Cell Apoptosis in PM2.5-Induced Lung Injury. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39940873 | PubMed |
| 39871571 | Natural Anticancer Drugs: Efficacy, Safety, and Future Challenges. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39871571 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| COL1A1 | 1277 | PubTator's text mining | https://conductscience.org/library/genes/1277 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34833334
GET https://conductscience.org/api/papers/v1/34833334/references?page=2